Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Third Edition BOGP (10)
Norway (1)
Other
Neurology/Parkinson's Disease (1)
Pharmaceutical Company (9)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Capacity and capabilities for engagement
Clinical study phase II